Table 1.

Baseline characteristics of subjects according to thyroid dysfunction.

Variable	Total	Overt hypothyroidism	Subclinical hypothyroidism	Euthyroid	Subclinical hyperthyroidism	Overt hyperthyroidism	p-value
2013–2015
Number (%)	5727	30 (0.66)	155 (2.84)	5382 (92.32)	137 (2.64)	23 (0.34)
Age	37.99 ± 0.23	48.72 ± 2.12	39.70 ± 1.62	37.76 ± 0.24	41.87 ± 1.52	35.31 ± 3.46	< 0.001
Sex (female)	2845 (47.93)	22 (76.66)	101 (65.11)	2639 (47.07)	69 (49.23)	14 (69.97)	< 0.001
Height	165.00 ± 0.13	160.57 ± 1.50	162.05 ± 0.77	165.17 ± 0.14	163.84 ± 0.78	159.89 ± 2.54	< 0.001
Weight	63.82 ± 0.18	63.42 ± 2.16	61.94 ± 1.02	63.92 ± 0.19	63.31 ± 1.14	56.85 ± 2.91	0.05
Waist circumference	79.15 ± 0.18	82.54 ± 1.69	78.96 ± 0.90	79.15 ± 0.18	79.13 ± 0.84	74.42 ± 2.52	0.11
BMI	23.30 ± 0.06	24.55 ± 0.68	23.49 ± 0.29	23.29 ± 0.06	23.43 ± 0.30	22.14 ± 0.86	0.21
Past history of hypertension	488 (9.07)	2 (7.28)	16 (12.01)	455 (8.96)	13 (10.61)	2 (4.27)	0.69
Current medication on hypertension	378 (7.15)	1 (4.43)	13 (9.57)	349 (7.01)	13 (10.61)	2 (4.27)	0.45
Systolic blood pressure	114.23 ± 0.25	116.63 ± 3.62	114.90 ± 1.36	114.15 ± 0.26	115.20 ± 1.53	118.09 ± 4.25	0.76
Fasting glucose	94.51 ± 0.22	97.78 ± 2.79	93.09 ± 0.87	94.52 ± 0.22	94.60 ± 0.96	95.82 ± 3.06	0.40
Triglyceride	114.48 ± 1.05	159.44 ± 18.15	119.32 ± 6.60	114.23 ± 1.06	111.51 ± 6.17	78.83 ± 6.22	< 0.001
TyG index	4.56 ± 0.00	4.75 ± 0.06	4.58 ± 0.03	4.56 ± 0.00	4.55 ± 0.03	4.41 ± 0.04	< 0.001
TPO positivity	316 (5.47)	16 (56.44)	35 (23.77)	246 (4.37)	13 (8.63)	6 (29.76)	< 0.001
2015
Number	1881	19	48	1758	50	6
Fasting glucose	94.75 ± 0.38	96.60 ± 3.90	90.89 ± 1.41	94.83 ± 0.39	94.99 ± 1.40	96.49 ± 6.78	0.09
Triglyceride	115.27 ± 1.75	170.86 ± 24.65	116.77 ± 13.26	114.74 ± 1.71	112.63 ± 11.00	70.12 ± 8.84	< 0.001
HOMA-IR	2.12 ± 0.05	2.40 ± 0.36	2.10 ± 0.24	2.12 ± 0.06	2.11 ± 0.46	2.77 ± 1.00	0.91

BMI body mass index, TyG index triglyceride glucose index, TPO thyroid peroxidase antibody, HOMA_IR homeostasis model assessment of insulin resistance.